Description

Stem cell therapeutics are being developed in order to fill the gaps in medical care and offer beneficial treatments for diseases that are currently inadequately treated or for which no therapeutic options exist. The stem cell therapeutics market is still in its infancy; currently, there are no licensed stem cell products in the United States. This research service presents a pipeline analysis of the U.S. stem cell therapeutics market. It highlights the current market landscape and provides profiles for companies actively developing stem cell therapeutics for the United States market.